Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCERT: Dimebon plus donepezil in mild-to-moderate Alzheimer's disease
2008-008005-21Phase 3Completed
- Sponsor
- Medivation
- Start
- Apr 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Dimebon + donepezil with Placebo + donepezil (2 arms). Primary endpoint: Global functional change (CIBIC-plus). Started Apr 2009; status: completed.
02
Drugs
latrepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-008005-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008005-21.